The challenge
The maker of Wegovy is threatening to sue and take regulatory action, saying Hims & Hers' new weight loss medication is illegal and calling it an "unapproved, inauthentic and untested knockoff semaglutide pill." "The action by Hims & Hers is illegal mass compounding that poses a significant risk to patient safety
Lets break it down: The Science Stuff (Simplified) Semaglutide mimics one hormone (GLP-1) Tirzepatide mimics two (GLP-1 + GIP) Both help regulate appetite, insulin, and blood sugar They're available as injectables , and in some programs including Josie you may be offered compounded oral tablets if appropriate
Weekly injectables: Wegovy (semaglutide) and Mounjaro (tirzepatide) Guidance: educational content, Q&A sessions with prescribing pharmacists, and a private community for patients Daily oral tablet formats are also mentioned on myBMIs site, though they arent listed in active treatment plans
GLP-1 agonists are ideal for individuals with a BMI of 27 or higher with obesity-related conditions or a BMI of 30 or greater
For example, doxorubicin-loaded exendin-4 nanoassemblies have been developed for insulinoma and metastatic GLP-1R-positive neutrophil extracellular trap (NET) targeting [346]
